Bucladesine

Content sourced from Wikipedia, licensed under CC BY-SA 3.0.

Bucladesine (also called dibutyryl cyclic adenosine monophosphate or db-cAMP) is a synthetic molecule that mimics the body’s natural signaling molecule cAMP. It is a cell-permeable version of cAMP and acts by inhibiting enzymes that break down cAMP, helping boost cAMP signaling inside cells.

Because it can enter cells easily, bucladesine is used in many laboratory studies to trigger cAMP-related responses in cells and tissues where natural cAMP responses are weak.

In research, bucladesine has been used to study neurite outgrowth in cultured neurons. In mouse studies, it affected seizure-related measures in a pentylenetetrazol model, with some doses reducing seizure latency and increasing threshold; combining bucladesine with other drugs like pentoxifylline showed an additive effect. It has also been shown to lessen morphine withdrawal symptoms in mice, and higher-dose combinations with a protein kinase inhibitor produced further attenuation.

Overall, bucladesine is a research tool to study cAMP signaling and is not approved as a medical treatment for humans.